| Literature DB >> 31841501 |
Sarah K Buddenborg1,2, Bishoy Kamel1, Lijing Bu1, Si-Ming Zhang1, Gerald M Mkoji3, Eric S Loker1.
Abstract
BACKGROUND: Schistosomiasis is one of the world's most common NTDs. Successful control operations often target snail vectors with the molluscicide niclosamide. Little is known about how niclosamide affects snails, including for Biomphalaria pfeifferi, the most important vector for Schistosoma mansoni in Africa. We used Illumina technology to explore how field-derived B. pfeifferi, either uninfected or harboring cercariae-producing S. mansoni sporocysts, respond to a sublethal treatment of niclosamide. This study afforded the opportunity to determine if snails respond differently to biotic or abiotic stressors, and if they reserve unique responses for when presented with both stressors in combination. We also examined how sporocysts respond when their snail host is treated with niclosamide. PRINCIPALEntities:
Mesh:
Substances:
Year: 2019 PMID: 31841501 PMCID: PMC6936870 DOI: 10.1371/journal.pntd.0006927
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1(A) Number of B. pfeifferi CDS (protein-coding sequences) up- and down-regulated in S. mansoni-infected snails untreated (Shedding), uninfected but molluscicide-treated snails (Molluscicide), and snails with both S. mansoni-infected and molluscicide treatment (Shedding + Molluscicide) when compared to uninfected untreated snails. (B) Venn diagrams showing shared and unique B. pfeifferi CDS between differentially expressed groups.
All snail features shared between B. glabrata [16] and B. pfeifferi that were significantly differentially expressed after treated with 0.15mg/L niclosamide.
| B. pfeifferi | Log2FC | B. glabrata | Log2FC | |
|---|---|---|---|---|
| ADP-ribosylation factor 3-like | evgTRINITY_DN92963_c1_g2_i1 | 5.10 | c13901 | 4.73 |
| ADP-ribosylation factor 3-like | evgTRINITY_DN92963_c1_g1_i1 | 4.45 | c13901 | 4.73 |
| Solute carrier family 28 member 3-like | evgTRINITY_DN88027_c1_g1_i4 | 6.78 | c27272 | 1.99 |
| Multidrug resistance 1-like | evgTRINITY_BU_DN81217_c7_g4_i1 | 2.72 | contig_14304 | 1.48 |
| Multidrug resistance 1-like | evgTRINITY_DN90366_c3_g1_i2 | 5.26 | contig_14304 | 1.48 |
| HSP 12 | evglcl|G0WVJSS02FHD9K | 2.29 | contig_7431 | 3.79 |
| HSP 12 | evglcl|G0WVJSS02JB97J | 1.98 | contig_7431 | 3.79 |
| HSP 70 | evgTRINITY_GG_25613_c6_g1_i1 | 1.09 | BGC03909 | 3.64 |
| Solute carrier family 28 member 3-like | evgTRINITY_DN88027_c1_g1_i3 | 3.79 | c27272 | 1.99 |
| Cytochrome p450 | evgTRINITY_BU_DN81631_c8_g1_i1 | 1.05 | c14547_rc | 3.10 |
| Cytochrome p450 | evgTRINITY_DN93193_c20_g1_i1 | 2.88 | c8814 | 2.88 |
| Baculoviral IAP repeat-containing 3-like | evgTRINITY_BU_DN78979_c0_g1_i2 | 1.69 | c17676_rc | 2.14 |
| Nuclear protein 1-like | evglcl|HJ4YRIA01D0DSV | 1.28 | contig_4627 | 2.20 |
| Nuclear protein 1-like | evglcl|HJ4YRIA02HBZUN | 1.01 | contig_4627 | 2.20 |
| Growth arrest and DNA damage-inducible alpha-like | evglcl|G0WVJSS02G7JUO | 1.85 | contig_8438 | 1.39 |
| Alpha-crystallin B chain | evglcl|HJ4YRIA01ERORD | 1.21 | contig_2362_rc | 1.79 |
| Sequestosome-1-like | evgTRINITY_DN29609_c0_g1_i1 | 1.00 | BGC02302 | 1.57 |
| Glycogen-binding subunit 76A-like | evgTRINITY_DN70212_c1_g1_i1 | 0.92 | c14016_rc | 1.09 |
| Methionine synthase reductase-like | evgTRINITY_DN77579_c0_g1_i1 | 0.71 | c41473 | 1.00 |
| Glutathione-independent glyoxalase hsp3103 | evgTRINITY_DN92822_c15_g1_i1 | -1.08 | contig_3480 | -1.10 |
| Thymidine kinase, cytosolic-like | evgTRINITY_DN90310_c10_g1_i1 | -1.29 | contig_10981 | -1.35 |
| Uncharacterized | evgTRINITY_DN89789_c4_g2_i1 | 2.39 | contig_12514_rc | 3.19 |
| Uncharacterized | evglcl|G0WVJSS01A5WAX | 3.89 | contig_6337_rc | 4.16 |
| Uncharacterized | evglcl|G0WVJSS01DEUAY | 1.60 | contig_3100 | 2.29 |
| Uncharacterized | evgTRINITY_DN88565_c20_g1_i1 | 2.00 | contig_3944_rc | 1.38 |
| Uncharacterized | evgTRINITY_DN22835_c0_g1_i1 | 1.33 | BGC02491 | 1.02 |
| Uncharacterized | evglcl|G0WVJSS01DKS66 | 1.36 | c43865_rc | 1.40 |
| Uncharacterized | evglcl|G0WVJSS02ITT0P | 0.82 | contig_7634_rc | 1.16 |
| Uncharacterized | evgTRINITY_GG_16388_c0_g2_i1 | 0.86 | c13164_rc | 1.09 |
| Uncharacterized | evgTRINITY_DN84827_c0_g2_i1 | -0.81 | c8798_rc | -1.13 |
| Uncharacterized | evgTRINITY_DN93461_c7_g1_i1 | -1.49 | c1870 | -1.80 |
Fig 2(A) Biomphalaria pfeifferi CYP (cytochrome p450s) and GST (glutathione-S-transferases) and (B) B. pfeifferi heat shock proteins (HSPs) up-regulated in response to sublethal niclosamide treatment. Data for B. glabrata from Zhang et al. [16].
Biomphalaria pfeifferi transcripts up-regulated in response to dual stressors (S. mansoni infection and sublethal niclosamide exposure) identified for their potential role in programmed cell death.
Except where noted, functions were obtained from Entrez Gene at https://www.ncbi.nlm.nih.gov/gene and UniProtKB at www.uniprot.org/uniprot.
| Transcript Description | Function |
|---|---|
| ABCA3 transmembrane transporter | Resistance to xenobiotics and engulfment during apoptosis |
| Growth arrest-specific protein 2-like | Cell cycle arrest; regulation of cell shape; may act as a cell death substrate for caspases |
| Glutaredoxin-2-like | Mitochondrial; response to hydrogen peroxide and regulation of apoptosis caused by oxidative stress |
| Calmodulin 2/4-like, 5, A-like | Can mediate the stress response calcium-dependent signaling that controls a variety of enzymes, ion channels, proteins, kinases, and phosphatases |
| Heparanase-like | Facilitates cell migration associated with metastasis, wound healing and inflammation |
| Catalase-like | Reduction of hydrogen peroxide |
| Caspase 3 and 8-like | TNF binding; endopeptidase activity involved in apoptosis |
| Tumor necrosis factor (TNF) and receptor | Induces cell death |
| Cathepsin-L-like | Lysosomal endopeptidase |
| Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) | Induces pro-apoptotic mitochondrial membrane permeability (Deniaud et al. 2007) |